RICERCA ITALIANA     

Programmi di ricerca simili:

• 1 - Caratterizzazione feno-genotipica dell'adattamento mentale al cancro e della risposta al trattamento con farmaci antidepressivi in oncologia
• 2 - Parkinson e parkinsonismi: epidemiologia, basi molecolari, modelli diagnostici e farmacogenetica
• 3 - Anoressia/Cachessia (CACS) e stress ossidativo correlati al cancro: approccio innovativo dietetico, farmaco-nutrizionale e farmacologico.
• 4 - CARATTERIZZAZIONE CLINICA, GENETICA ED EVOLUTIVA DEI FENOMENI EPILETTICI NEL SONNO E DEI DISTURBI DELL'AROUSAL

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze mediche
  • PSCHIATRIA

Classificazione brevettuale

• HUMAN NECESSITIES
  • MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY (measurement of bio-electric currents A61B; electrosurgical apparatus or circuits therefor A61B17/36; physical therapy arrangements in general A61H; anaesthetic apparatus in general A61M; incandescent lamps H01K; infra-red radiators for heating H05B)
    • PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES (bringing into special physical form A61J [N: mechanical aspects]; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; compounds per se C01, C07, C08, C12N; soap compositions C11D; micro-organisms per se C12N) [C0203]
    • THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

Classificazione geografica

• Regione: Lombardia

Bibliografia

Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R. Influence
of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003 Jul 18;301(5631):386-9.
Clark CP, Frank LR, Brown GG (2001): Sleep deprivation, EEG, and functional MRI in depression: preliminary results.
Neuropsychopharmacology 25:S79-84.
Elliott R, Rubinsztein JS, Sahakian BJ, Dolan RJ. Selective attention to emotional stimuli in a verbal go/no-go task: an fMRI study.
Neuroreport. 2000;11:1739-1744.
Elliott, R., Rubinsztein, J.S., Sahakian, B.J., Dolan, R.J., 2002. The neural basis of mood-congruent processing biases in depression.
Archives of General Psychiatry 59, 597-604.
First MB, Spitzer RL, Gibbon M, Williams BW, Benjamin L (1990): Structured Clinical Interview for DSM-IV Axis II Personality
Disorders (SCID-II). New York: Biometrics Research Department, New York State Psychiatric Institute.
Hamilton M (1967): Development of a rating scale for primary depressive illness. British Journal of Social & Clinical Psychology
6:278-296.
Lahiri DK, Nurnberger JIJ (1991): A rapid non-enzimatic method for the preparation of HMW DNA from blood for RFLP studies.
Nucleic Acid Research 19:5444.
Leckman JF, Sholomskas D, Thompson WD, Belanger A, Weissman MM (1982): Best estimate of lifetime psychiatric diagnosis: a
methodological study. Archives of General Psychiatry 39:879-83.
Mayberg HS. Modulating dysfunctional limbic-cortical circuits in depression: towards
development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull. 2003;65:193-207. Review.
Murphy FC, Sahakian BJ, Rubinsztein JS, Michael A, Rogers RD, Robbins TW, Paykel ES (1999): Emotional bias and inhibitory
control processes in mania and depression. Psychol Med 29:1307-21.
Nakamura M, Ueno S, Sano A, Tanabe H (2000): The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Molecular Psychiatry 5:32-38.
Serretti, A., et al, 2002. Pharmacogenetics in affective disorders. European Jourmal of Pharmacology 438, 117-128.
Serretti A, Zanardi R, Rossini D, Cusin C, Lilli R, Smeraldi E (2001): Influence of tryptophan hydroxylase and serotonin transporter
genes on fluvoxamine antidepressant activity. Molecular Psychiatry 6:586-592.
Smeraldi E, Zanardi R, Benedetti F, Dibella D, Perez J, Catalano M (1998): Polymorphism Within the Promoter of the Serotonin
Transporter Gene and Antidepressant Efficacy of Fluvoxamine. Molecular Psychiatry 3:508-511.
Spitzer RL, Williams JBW, Gibbon M, First MB (1990): Structured Clinical Interview for DSM-III-R, Version 1.0 (SCID). American
Psychiatric Press, Washington, DC.
Zanardi R, Benedetti F, DiBella D, Catalano M, Smeraldi E (2000): Efficacy of paroxetine in depression is influenced by a
functional polymorphism within the promoter of serotonin transporter gene. Journal of Clinical Psychopharmacology 20:105-107.
Wu JC, Buchsbaum M, Bunney WE Jr. Clinical neurochemical implications of sleep deprivation's effects on the anterior cingulate of
depressed responders. Neuropsychopharmacology. 2001 Nov;25(5 Suppl):S74-8. Review.

Parole Chiave

DISTURBO BIPOLARE; DEPRESSIONE; FARMACOGENETICA; IMAGING CEREBRALE